Literature DB >> 22273353

Blindness and low vision in Germany 1993-2009.

Christian Wolfram1, Norbert Pfeiffer.   

Abstract

PURPOSE: To describe the development of the prevalence of blindness and low vision in the German population between 1993 and 2009 with respect to major demographic changes and to investigate how the prevalence of blindness would have developed without demographic aging.
METHODS: Investigation of the prevalence for blindness and low vision in the German population on the basis of the official German statistics for severely handicapped people and population statistics between 1993 and 2009. Age-specific prevalence rates and the prevalence based on a standardized population were calculated and the progression is demonstrated.
RESULTS: The overall prevalence of blindness and low vision in Germany increased between 1993 and 2009 by 12.3% from 314,404 to 352,943 subjects. The absolute number of blind or visually impaired persons in the eldest group (75 years and above) has grown by 38.2% from 126,023 to 174,127 subjects. At the same time, both age-specific prevalence rates as well as the prevalence that was based on a standardized population decreased, matching more than 30,000 fewer cases of blindness in 2009 as compared to 1993.
CONCLUSIONS: The increase in absolute prevalence numbers for blindness and low vision implies an increase in the ophthalmic workload. At the same time, the decrease in the age-specific and standardized prevalence indicates possible improvements in the overall eye health status of the population since 1993.

Entities:  

Mesh:

Year:  2012        PMID: 22273353     DOI: 10.3109/09286586.2011.628136

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  10 in total

1.  [Preservatives from the perspective of glaucoma surgery].

Authors:  H Thieme; K K van der Velden
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

2.  [Epidemiology of severe visual impairment and blindness of old people in Germany].

Authors:  M M Mauschitz; J Q Li; P P Larsen; J Köberlein-Neu; F G Holz; M M B Breteler; R P Finger
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

3.  [Outcomes and health services research in ophthalmology].

Authors:  C Wolfram; N Pfeiffer
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

4.  The Prevalence of Visual Impairment in the Adult Population.

Authors:  Christian Wolfram; Alexander K Schuster; Heike M Elflein; Stefan Nickels; Andreas Schulz; Philipp S Wild; Manfred E Beutel; Maria Blettner; Thomas Münzel; Karl J Lackner; Norbert Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2019-04-26       Impact factor: 5.594

5.  Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany.

Authors:  Heiner Claessen; Jutta Genz; Bernd Bertram; Christoph Trautner; Guido Giani; Iris Zöllner; Andrea Icks
Journal:  Eur J Epidemiol       Date:  2012-06-19       Impact factor: 8.082

Review 6.  Current status of epibulbar anti-glaucoma drainage devices in glaucoma surgery.

Authors:  Hagen Thieme
Journal:  Dtsch Arztebl Int       Date:  2012-10-05       Impact factor: 5.594

7.  Blindness and visual impairment in Germany: a slight fall in prevalence.

Authors:  Robert P Finger; Bernd Bertram; Christian Wolfram; Frank G Holz
Journal:  Dtsch Arztebl Int       Date:  2012-07-09       Impact factor: 5.594

8.  [Increase in examinations for cataracts, glaucoma, diabetic retinopathy and age-related macular degeneration : Comparative cross-sectional study between 2010 and 1997 in ophthalmological practices].

Authors:  B Bertram; C Gante; R-D Hilgers
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

9.  Effect of reduced visual acuity on precision of two-dimensional tracing movements.

Authors:  Dmitry Domkin; Hans O Richter; Christina Zetterlund; Lars-Olov Lundqvist
Journal:  J Optom       Date:  2015-05-19

10.  The prevalence and causes of visual impairment and blindness among older adults in the city of Lodz, Poland.

Authors:  Michal S Nowak; Janusz Smigielski
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.